Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT06496633
Eligibility Criteria:
Inclusion Criteria:
1. The patient is at least 18 years of age.
2. Hypertrophic cardiomyopathy with alcohol ablation, LVOT pressure difference at rest or after excitation ≥ 50mmHg;
3. The clinical symptoms are obvious, fatigue, shortness of breath, exhaustive angina pectoris, syncope, etc. seriously affect the quality of life, and the effect of adequate drug treatment is not good or the side effects of drugs cannot be tolerated;
4. After the informed consent of the patient and his family, he voluntarily underwent Liwen surgery.
Exclusion Criteria:
1. Non-obstructive hypertrophic cardiomyopathy;
2. Left ventricular hypertrophy due to secondary causes, such as increased preload, history of taking drugs suspected of causing left ventricular hypertrophy, etc.
3. Preoperative complications with other heart diseases require surgical treatment.
4. The disease will make it difficult to evaluate treatment (e.g. cancer, severe metabolic diseases, mental illness, etc.).
5. Patients who have participated in any clinical trial of drugs and/or medical devices within 1 month before surgery or during follow-up;
6. Pregnant and breastfeeding women;
7. Patients with poor adherence may not cooperate during treatment or follow-up.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06496633
Study Brief:
Protocol Section:
NCT06496633